Hannes M. Schröder

Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

Andreas Kerstan, Kathrin Dieter, Elke Niebergall‐Roth et al. · Stem Cell Research & Therapy · 2022 · 70 citations · Full text

Medicine, Bioengineering, Molecular Medicine +17

In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials

Nils Tappenbeck, Hannes M. Schröder, Elke Niebergall‐Roth et al. · Cytotherapy · 2019 · 54 citations · Full text

Engineering, Biomedical Sciences, Biotechnology +16

Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data

Andreas Kerstan, Elke Niebergall‐Roth, Jasmina Esterlechner et al. · Cytotherapy · 2020 · 51 citations · Full text

Pharmacy, Biotechnology, Immunology +17

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

Alexandra Norrick, Jasmina Esterlechner, Elke Niebergall‐Roth et al. · Stem Cell Research & Therapy · 2021 · 37 citations · Full text

Pharmacy, Pharmaceutical Biotechnology, Translational Sciences +17

Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

Andreas Kerstan, Kathrin Dieter, Elke Niebergall‐Roth et al. · JID Innovations · 2021 · 37 citations · Full text

Veterinary Medicine, Clinical Sciences, Immunology +15